Go back

Qsauri
"B"

bulk pharmaceuticals
Guideline or reference source
ECA GAMP5 Approach and Risk Management
Definition
Mean materials (both pharmacologically active and inactive) which are intended for use as a component of a drug or biological product. These include materials manufactured by processes such as: (1) chemical synthetics; (2) fermentation; (3) recombinant DNA or other biotechnology methods, (4) isolation/recovery from natural sources, or (5) any combination of these processes.
Related Term
bulk product
 

Send comments to info@celegence.com Please read disclaimer before using Qsauri.